The elusive Luminal B breast cancer and the mysterious chemokines.

Autor: de Araújo RA; Medical Faculty, Federal University of Uberlândia, Avenida Pará, Bloco 2U, 1720, Campus Umuarama, Uberlândia, MG, CEP 38400-902, Brazil. rogeriodearaujo@ufu.br.; Cancer Research and Prevention Nucleus, Grupo Luta Pela Vida, Cancer Hospital in Uberlândia, Uberlândia, MG, CEP 38405-302, Brazil. rogeriodearaujo@ufu.br., da Luz FAC; Cancer Research and Prevention Nucleus, Grupo Luta Pela Vida, Cancer Hospital in Uberlândia, Uberlândia, MG, CEP 38405-302, Brazil., da Costa Marinho E; Cancer Research and Prevention Nucleus, Grupo Luta Pela Vida, Cancer Hospital in Uberlândia, Uberlândia, MG, CEP 38405-302, Brazil., Nascimento CP; Cancer Research and Prevention Nucleus, Grupo Luta Pela Vida, Cancer Hospital in Uberlândia, Uberlândia, MG, CEP 38405-302, Brazil., Mendes TR; Cancer Research and Prevention Nucleus, Grupo Luta Pela Vida, Cancer Hospital in Uberlândia, Uberlândia, MG, CEP 38405-302, Brazil., Mosca ERT; Cancer Research and Prevention Nucleus, Grupo Luta Pela Vida, Cancer Hospital in Uberlândia, Uberlândia, MG, CEP 38405-302, Brazil., de Andrade Marques L; Cancer Research and Prevention Nucleus, Grupo Luta Pela Vida, Cancer Hospital in Uberlândia, Uberlândia, MG, CEP 38405-302, Brazil., Delfino PFR; Cancer Research and Prevention Nucleus, Grupo Luta Pela Vida, Cancer Hospital in Uberlândia, Uberlândia, MG, CEP 38405-302, Brazil., Antonioli RM; Cancer Research and Prevention Nucleus, Grupo Luta Pela Vida, Cancer Hospital in Uberlândia, Uberlândia, MG, CEP 38405-302, Brazil., da Silva ACAL; Medical Faculty, Federal University of Uberlândia, Avenida Pará, Bloco 2U, 1720, Campus Umuarama, Uberlândia, MG, CEP 38400-902, Brazil., Dos Reis Monteiro MLG; Medical Faculty, Federal University of Uberlândia, Avenida Pará, Bloco 2U, 1720, Campus Umuarama, Uberlândia, MG, CEP 38400-902, Brazil., Neto MB; Department of Basic and Environmental Sciences, University of São Paulo, Lorena, SP, CEP 12602-810, Brazil., Silva MJB; Laboratory of Tumor Biomarkers and Osteoimmunology, Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, MG, CEP 38405-320, Brazil.

Publikováno v: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2023 Nov; Vol. 149 (14), pp. 12807-12819. Date of Electronic Publication: 2023 Jul 17.

Epidermal growth factor receptor (EGFR) expression in the serum of patients with triple-negative breast carcinoma: prognostic value of this biomarker.

Autor: de Araújo RA; Federal University of Uberlândia, Avenida Pará, Bloco 2U, 1720, Campus Umuarama, Uberlândia, MG, CEP 38400-902, Brazil.; Cancer Research and Prevention Nucleus, Grupo Luta Pela Vida, Cancer Hospital in Uberlândia, Uberlândia, MG, CEP 38405-302, Brazil.; https://orcid.org/0000-0003-4653-6786., da Luz FAC; Cancer Research and Prevention Nucleus, Grupo Luta Pela Vida, Cancer Hospital in Uberlândia, Uberlândia, MG, CEP 38405-302, Brazil.; https://orcid.org/0000-0002-9381-4913., da Costa Marinho E; Cancer Research and Prevention Nucleus, Grupo Luta Pela Vida, Cancer Hospital in Uberlândia, Uberlândia, MG, CEP 38405-302, Brazil.; https://orcid.org/0000-0002-1307-9104., Nascimento CP; Cancer Research and Prevention Nucleus, Grupo Luta Pela Vida, Cancer Hospital in Uberlândia, Uberlândia, MG, CEP 38405-302, Brazil.; https://orcid.org/0000-0002-0955-8559., de Andrade Marques L; Cancer Research and Prevention Nucleus, Grupo Luta Pela Vida, Cancer Hospital in Uberlândia, Uberlândia, MG, CEP 38405-302, Brazil.; https://orcid.org/0000-0002-2734-8352., Delfino PFR; Cancer Research and Prevention Nucleus, Grupo Luta Pela Vida, Cancer Hospital in Uberlândia, Uberlândia, MG, CEP 38405-302, Brazil.; https://orcid.org/0000-0002-2196-9318., Antonioli RM; Cancer Research and Prevention Nucleus, Grupo Luta Pela Vida, Cancer Hospital in Uberlândia, Uberlândia, MG, CEP 38405-302, Brazil.; https://orcid.org/0000-0003-3886-1562., Araújo BJ; São Paulo State Cancer Institute of the Medical School of the University of São Paulo, São Paulo, SP, CEP 38405-302, Brazil.; https://orcid.org/0000-0003-4892-9911., da Silva ACAL; Federal University of Uberlândia, Avenida Pará, Bloco 2U, 1720, Campus Umuarama, Uberlândia, MG, CEP 38400-902, Brazil.; https://orcid.org/0000-0002-8220-938X., Dos Reis Monteiro MLG; Federal University of Uberlândia, Avenida Pará, Bloco 2U, 1720, Campus Umuarama, Uberlândia, MG, CEP 38400-902, Brazil.; https://orcid.org/0000-0002-7961-6996., Neto MB; Department of Basic and Environmental Sciences, University of São Paulo, Lorena, SP, CEP 12602-810, Brazil.; https://orcid.org/0000-0003-4292-7800., Silva MJB; Laboratory of Tumor Biomarkers and Osteoimmunology, Institute of Biomedical Sciences, Federal University of Uberlândia, Uberlândia, MG, CEP 38405-320, Brazil.; https://orcid.org/0000-0002-5807-4286.

Publikováno v: Ecancermedicalscience [Ecancermedicalscience] 2022 Jul 20; Vol. 16, pp. 1431. Date of Electronic Publication: 2022 Jul 20 (Print Publication: 2022).

The effectiveness of radiotherapy in preventing disease recurrence after breast cancer surgery.

Autor: Luz FACD; Center for Cancer Prevention and Research, Uberlandia Cancer Hospital, Minas Gerais, Brazil; Laboratory of Tumor Biomarkers and Osteoimmunology, Institute of Biomedical Sciences, Federal University of Uberlandia, Minas Gerais, Brazil. Electronic address: felipe@hospitaldocancer.org.br., Marinho EDC; Center for Cancer Prevention and Research, Uberlandia Cancer Hospital, Minas Gerais, Brazil., Nascimento CP; Center for Cancer Prevention and Research, Uberlandia Cancer Hospital, Minas Gerais, Brazil., Marques LA; Center for Cancer Prevention and Research, Uberlandia Cancer Hospital, Minas Gerais, Brazil., Duarte MBO; Department of Radiotherapy, Oncology Sector, Clinical Hospital of the Federal University of Uberlandia, Minas Gerais, Brazil., Delfino PFR; Center for Cancer Prevention and Research, Uberlandia Cancer Hospital, Minas Gerais, Brazil., Antonioli RM; Center for Cancer Prevention and Research, Uberlandia Cancer Hospital, Minas Gerais, Brazil., Araújo RA; Center for Cancer Prevention and Research, Uberlandia Cancer Hospital, Minas Gerais, Brazil; Medical Faculty, Federal University of Uberlandia, Minas Gerais, Brazil., Silva MJB; Laboratory of Tumor Biomarkers and Osteoimmunology, Institute of Biomedical Sciences, Federal University of Uberlandia, Minas Gerais, Brazil.

Publikováno v: Surgical oncology [Surg Oncol] 2022 May; Vol. 41, pp. 101709. Date of Electronic Publication: 2022 Feb 01.

The benefits of trastuzumab in the treatment of HER2+ breast cancer as a function of exposure time.

Autor: da Luz FAC; Center for Cancer Prevention and Research, Uberlandia Cancer Hospital, Av Amazonas nº 1996, Umuarama, Uberlândia, Minas Gerais, 38.405-302, Brazil.; Laboratory of Tumor Biomarkers and Osteoimmunology, Institute of Biomedical Sciences, Federal University of Uberlandia, Av Pará nº 1720, Bloco 6T, room 07, Umuarama, Uberlândia, Minas Gerais, 38.405-320, Brazil.; https://orcid.org/0000-0002-9381-4913., da Costa Marinho E; Center for Cancer Prevention and Research, Uberlandia Cancer Hospital, Av Amazonas nº 1996, Umuarama, Uberlândia, Minas Gerais, 38.405-302, Brazil.; https://orcid.org/0000-0002-1307-9104., Nascimento CP; Center for Cancer Prevention and Research, Uberlandia Cancer Hospital, Av Amazonas nº 1996, Umuarama, Uberlândia, Minas Gerais, 38.405-302, Brazil.; https://orcid.org/0000-0002-0955-8559., de Andrade Marques L; Center for Cancer Prevention and Research, Uberlandia Cancer Hospital, Av Amazonas nº 1996, Umuarama, Uberlândia, Minas Gerais, 38.405-302, Brazil.; https://orcid.org/0000-0002-2734-8352., Delfino PFR; Center for Cancer Prevention and Research, Uberlandia Cancer Hospital, Av Amazonas nº 1996, Umuarama, Uberlândia, Minas Gerais, 38.405-302, Brazil.; https://orcid.org/0000-0002-2196-9318., Antonioli RM; Center for Cancer Prevention and Research, Uberlandia Cancer Hospital, Av Amazonas nº 1996, Umuarama, Uberlândia, Minas Gerais, 38.405-302, Brazil.; https://orcid.org/0000-0003-3886-1562., Silva MJB; Laboratory of Tumor Biomarkers and Osteoimmunology, Institute of Biomedical Sciences, Federal University of Uberlandia, Av Pará nº 1720, Bloco 6T, room 07, Umuarama, Uberlândia, Minas Gerais, 38.405-320, Brazil.; https://orcid.org/0000-0002-5807-4286., de Araújo RA; Center for Cancer Prevention and Research, Uberlandia Cancer Hospital, Av Amazonas nº 1996, Umuarama, Uberlândia, Minas Gerais, 38.405-302, Brazil.; Faculty of Medicine, Federal University of Uberlandia, Av Pará nº 1720, Bloco 6T2u, room 07, Umuarama, Uberlândia, Minas Gerais, 38.400-902, Brazil.; https://orcid.org/0000-0003-4653-6786.

Publikováno v: Ecancermedicalscience [Ecancermedicalscience] 2022 Jan 20; Vol. 16, pp. 1347. Date of Electronic Publication: 2022 Jan 20 (Print Publication: 2022).